Beranda › Skleroderma › North Carolina › Durham
Uji klinis Skleroderma di Durham, NC
7 studi untuk Skleroderma mencari peserta di lokasi sekitar Durham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Menerima pesertaFase 1
- Duke University Medical Center, Durham
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Menerima pesertaFase 1
- University of North Carolina TraCS Institute - CTRC, Chapel Hill · 10 mi jauhnya
Platform Clinical Study for Conquering Scleroderma
Menerima pesertaFase 2
- Duke University Medical Center, Durham
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Menerima pesertaFase 2/3
- Duke University, Durham
A Study of AZD0120 in Autoimmune Diseases
Menerima pesertaFase 1
- Research Site, Chapel Hill · 10 mi jauhnya
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Menerima pesertaFase 1
- Duke University, Durham
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Menerima pesertaFase 1
- Duke University Health System, Durham
Uji klinis Skleroderma di kota lain
- New York City, NY11 studi
- Chicago, IL10 studi
- Ann Arbor, MI10 studi
- Houston, TX9 studi
- Los Angeles, CA7 studi
- Boston, MA7 studi
- Baltimore, MD6 studi
- New Orleans, LA6 studi
- Philadelphia, PA6 studi
- Pittsburgh, PA5 studi
- Dallas, TX5 studi
- Phoenix, AZ4 studi
Studi lain di Durham
- Kanker Payudara63 studi
- Kanker (semua jenis)58 studi
- Kanker Paru Non-Sel Kecil39 studi
- Mieloma Multipel37 studi
- Kanker Metastatik33 studi
- Leukemia Mieloid Akut33 studi
- Kanker Prostat32 studi
- Kanker Paru32 studi
- Kanker Kolorektal28 studi
- Leukemia Limfositik Kronis27 studi
- Kanker Ovarium27 studi
- Gagal Jantung26 studi
Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.